Horizon Technology Finance Management, LLC is a venture lending firm that specializes in providing structured debt products, including senior and subordinated venture loans, secured working capital loans, and equipment loans, to development-stage companies primarily in the technology and life sciences sectors. Founded in 2003 and headquartered in Farmington, Connecticut, with additional offices in Pleasanton, California, and Reston, Virginia, Horizon focuses on investments in areas such as cloud computing, biotechnology, and alternative energy. The firm targets companies in the Mid-Atlantic and Western regions of the United States, offering loans ranging from $1 million to $25 million, with repayment terms of up to 48 months. With a team that has collectively originated over $5 billion in venture loans, Horizon aims to support innovative companies by providing essential capital to fuel their growth.
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company focused on developing proprietary prescription medications that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs). The company aims to address significant therapeutic needs by offering innovative, controlled-release formulations that enhance dosing precision, safety, efficacy, and patient convenience. NHP's product pipeline leverages proprietary technologies and intellectual property licensed from Yale University, allowing the development of specialty drugs for new therapeutic indications. Through its innovative platform, NHP seeks to provide premium pharmaceutical solutions that meet the evolving needs of patients and healthcare providers.
ZetrOZ
Debt Financing in 2014
ZetrOZ specializes in innovative ultrasound technology. It manufactures and delivers therapeutic systems, including veterinary wearable ultrasound devices, high-intensity focused ultrasound systems for biomedical research, and various transducer control systems. The company's products cater to applications such as physiotherapy, drug delivery, ultrasonic sealing, cleaning, and sterilization. ZetrOZ was founded in 2009 and is headquartered in Trumbull, Connecticut.
Mederi Therapeutics
Debt Financing in 2013
Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease states affecting the human digestive system. All Mederi therapies are outpatient, minimally invasive, and promote rapid recovery. Mederi Therapeutics is located in Greenwich, Connecticut.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.